Huang highlighted that skincare brands accounted for 61.1% of total net revenues in the fourth quarter and said the company recorded net income under both GAAP and non-GAAP measures for the period.CFO Donghao Yang said fourth-quarter 2025 total net revenues increased 20.1% year over year to RMB 1.38 billion, up from RMB 1.15 billion in the prior-year period. The increase was attributed primarily to a 51.9% rise in skincare brand revenue, partially offset by a 9.1% decline in color cosmetics brand revenue.Hu ...

On end markets, Sanghera and Keher emphasized an accelerating shift toward applied segments. Life science research tools represented 66% of revenue and grew 15% in 2025, which the company characterized as an outperformance versus competitors amid a difficult market backdrop. Applied end markets grew faster, led by clinical growth of 59%, with biopharma up 30% and applied industrial up 27%. Management said the applied mix increased to roughly 34% from about 30% year over year, which they said aligned broadly ...

Tate & Lyle logo Tate & Lyle (LON:TATE) said trading in its third quarter was in line with expectations and consistent with the first half, while the company reiterated that its full-year guidance remains unchanged, according to comments on its Q3 trading statement call led by Chief Executive Nick Hampton and Chief Financial Officer Sarah Kuijlaars. On a pro forma basis and in constant currency, revenue was 2% lower in the quarter, which management attributed to “continued muted market demand,” with per ...

Core Viewpoint - Apple has launched the iPhone 17e, a more affordable smartphone model priced at $599 with 256 gigabytes of storage, aiming to maintain its market share in a competitive global handset market [1][2] Group 1: Product Launch - The iPhone 17e is positioned as a stronger value option by offering higher storage at the same price point, which is expected to attract new users [2] - The launch comes amid rising memory chip prices due to a global shortage, indicating that Apple is willing to absorb some component cost pressures [1] Group 2: Market Strategy - Analysts perceive the higher storage at the same starting price as effectively a price cut, as customers previously had to pay more for higher capacity [2] - This strategy is aimed at defending market share against competitors who are facing tighter supply constraints [2]

With mortgage rates still hovering in the 6% to 7% range, even a small rate cut can make a meaningful difference in your monthly payment. But exactly how much does a quarter-point drop actually save you? The answer depends on your loan size, but the savings are more significant than most people realize. Here’s the math broken down for loans ranging from $300,000 to $1 million. The Quick Answer: $48 to $160 Per Month For every 0.25% rate reduction on a 30-year fixed mortgage, your monthly payment drops ...

The AI software and data analytics company has a deep relationship with U.S. defense and intelligence operations. ...

Group 1 - The New York Stock Exchange (NYSE) provided a pre-market update highlighting various events, including the participation of Georgia Governor Brian Kemp and Atlanta Mayor Andre Dickens in a countdown to the FIFA World Cup 2026 [1] - Deloitte's CTO Bill Briggs is set to discuss the company's new Enterprise AI Navigator solution on NYSE Live, emphasizing its value generation for businesses [1] - Donaldson (NYSE: DCI) will celebrate the appointment of its new CEO Richard Lewis by ringing the Closing Bell, marking a significant moment in the company's 111-year history [1] Group 2 - Equities experienced a decline in pre-market trading following military actions by the U.S. and Israel against Iran over the weekend [1]

On February 17, 2026, Ananym Capital Management disclosed the sale of 217,684 shares of Sotera Health (NASDAQ:SHC), with an estimated transaction value of $3.60 million based on quarterly average pricing. What happened According to an SEC filing dated February 17, 2026, Ananym Capital Management reduced its position in Sotera Health by 217,684 shares. The estimated value of the sale, based on the filing quarter’s average price, was $3.60 million. The fund’s quarter-end position in the company shifted by ...

SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between August 3, 2023 and December 26, 2025, both dates inclusive (the “Class Period”), have until Monday, April 6, 2026 to seek appointment as lead plaintiff of the Ultragenyx class action lawsuit. Captioned Bailey v. Ultragenyx Pharmaceutical Inc., No. 26-cv-01097 (N.D. Cal.), the Ultragenyx class action lawsuit charges Ultragenyx a ...

Airline stocks tumble amid a wave of suspended, canceled flights to the Middle East. Cruise lines, booking firms retreat. ...